Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BL-M07D1 in Advanced Colorectal Cancer
NCT07730489Phase 3Not yet recruiting
- Sponsor
- Biokin Pharmaceutical
- Start
- Aug 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 3 trial of BL-M07D1 in colorectal cancer (CRC), sponsored by Biokin Pharmaceutical. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
BL-M07D1
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07730489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07730489.